ETHACRYNATE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Ethacrynate Sodium patents expire, and when can generic versions of Ethacrynate Sodium launch?
Ethacrynate Sodium is a drug marketed by Mylan Institutional, Par Sterile Products, Vpi Pharms Inc, and Zydus Pharms. and is included in four NDAs.
The generic ingredient in ETHACRYNATE SODIUM is ethacrynate sodium. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ethacrynate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethacrynate Sodium
A generic version of ETHACRYNATE SODIUM was approved as ethacrynate sodium by PAR STERILE PRODUCTS on July 29th, 2015.
Summary for ETHACRYNATE SODIUM
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| Patent Applications: | 310 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ETHACRYNATE SODIUM at DailyMed |
Pharmacology for ETHACRYNATE SODIUM
| Drug Class | Loop Diuretic |
| Physiological Effect | Increased Diuresis at Loop of Henle |
US Patents and Regulatory Information for ETHACRYNATE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | ETHACRYNATE SODIUM | ethacrynate sodium | INJECTABLE;INJECTION | 204634-001 | Aug 23, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Zydus Pharms | ETHACRYNATE SODIUM | ethacrynate sodium | INJECTABLE;INJECTION | 207758-001 | Nov 17, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Par Sterile Products | ETHACRYNATE SODIUM | ethacrynate sodium | INJECTABLE;INJECTION | 205473-001 | Jul 29, 2015 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Vpi Pharms Inc | ETHACRYNATE SODIUM | ethacrynate sodium | INJECTABLE;INJECTION | 208663-001 | Jun 9, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
